Ars Pharmaceuticals Inc (SPRY)

Sales/Maturities of Investments

$267.48M

TTM · Period ending: · USD

SPRY logo

SPRY Sales/Maturities of Investments

Latest reported$267.48M
SPRY TTM Sales/Maturities of Investments ($0.00 → $267.48M)
High-resolution chart · PNG

SPRY sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ars Pharmaceuticals Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
267,484,000
286,000,000
307,000,000
299,000,000
271,500,000
266,500,000
258,000,000
251,000,000
250,000,000
220,000,000
185,000,000
125,000,000
65,000,000
20,000,000
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.